94 related articles for article (PubMed ID: 14557067)
1. Expression modes of interferon-alpha inducible genes in sensitive and resistant human melanoma cells stimulated with regular and pegylated interferon-alpha.
Certa U; Wilhelm-Seiler M; Foser S; Broger C; Neeb M
Gene; 2003 Oct; 315():79-86. PubMed ID: 14557067
[TBL] [Abstract][Full Text] [Related]
2. High density oligonucleotide array analysis of interferon- alpha2a sensitivity and transcriptional response in melanoma cells.
Certa U; Seiler M; Padovan E; Spagnoli GC
Br J Cancer; 2001 Jul; 85(1):107-14. PubMed ID: 11437411
[TBL] [Abstract][Full Text] [Related]
3. Pegylated and conventional interferon-alpha induce comparable transcriptional responses and inhibition of tumor growth in a human melanoma SCID mouse xenotransplantation model.
Krepler C; Certa U; Wacheck V; Jansen B; Wolff K; Pehamberger H
J Invest Dermatol; 2004 Oct; 123(4):664-9. PubMed ID: 15373770
[TBL] [Abstract][Full Text] [Related]
4. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.
Leaman DW; Chawla-Sarkar M; Jacobs B; Vyas K; Sun Y; Ozdemir A; Yi T; Williams BR; Borden EC
J Interferon Cytokine Res; 2003 Dec; 23(12):745-56. PubMed ID: 14769151
[TBL] [Abstract][Full Text] [Related]
5. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha induces reversible DNA demethylation of the interferon-induced transmembrane protein-3 core promoter in human melanoma cells.
Scott R; Siegrist F; Foser S; Certa U
J Interferon Cytokine Res; 2011 Aug; 31(8):601-8. PubMed ID: 21413873
[TBL] [Abstract][Full Text] [Related]
8. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.
Tracey L; Villuendas R; Ortiz P; Dopazo A; Spiteri I; Lombardia L; Rodríguez-Peralto JL; Fernández-Herrera J; Hernández A; Fraga J; Dominguez O; Herrero J; Alonso MA; Dopazo J; Piris MA
Am J Pathol; 2002 Nov; 161(5):1825-37. PubMed ID: 12414529
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional program associated with IFN-alpha response of renal cell carcinoma.
Banerjee D; Chadalavada RS; Bourdon V; Korkola JE; Motzer RJ; Chaganti RS
J Interferon Cytokine Res; 2006 Mar; 26(3):156-70. PubMed ID: 16542138
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells.
Brassard DL; Delorenzo MM; Cox S; Leaman DW; Sun Y; Ding W; Gavor S; Spond J; Goodsaid F; Bordens R; Grace MJ
J Interferon Cytokine Res; 2004 Aug; 24(8):455-69. PubMed ID: 15320959
[TBL] [Abstract][Full Text] [Related]
11. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.
Singh RK; Gutman M; Bucana CD; Sanchez R; Llansa N; Fidler IJ
Proc Natl Acad Sci U S A; 1995 May; 92(10):4562-6. PubMed ID: 7753843
[TBL] [Abstract][Full Text] [Related]
12. Modulation of p53 expression by human recombinant interferon-alpha2a correlates with abrogation of cisplatin resistance in a human melanoma cell line.
Davol PA; Goulette FA; Frackelton AR; Darnowski JW
Cancer Res; 1996 Jun; 56(11):2522-6. PubMed ID: 8653690
[TBL] [Abstract][Full Text] [Related]
13. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
14. Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma.
Zocco MA; Carloni E; Pescatori M; Saulnier N; Lupascu A; Nista EC; Novi M; Candelli M; Cimica V; Mihm S; Gasbarrini G; Ramadori G; Gasbarrini A
Dig Liver Dis; 2006 Aug; 38(8):563-77. PubMed ID: 16807150
[TBL] [Abstract][Full Text] [Related]
15. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.
Der SD; Zhou A; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15623-8. PubMed ID: 9861020
[TBL] [Abstract][Full Text] [Related]
16. Interferon-a sensitivity in melanoma cells: detection of potential response marker genes.
Certa U; Seiler M; Padovan E; Spagnoli GC
Recent Results Cancer Res; 2002; 160():85-91. PubMed ID: 12079243
[TBL] [Abstract][Full Text] [Related]
17. [The interferons: pharmacology, mechanism of action, tolerance and side effects].
Arnaud P
Rev Med Interne; 2002 Nov; 23 Suppl 4():449s-458s. PubMed ID: 12481400
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and transforming growth factor-beta co-induce growth inhibition of human tumor cells.
Foser S; Redwanz I; Ebeling M; Heizmann CW; Certa U
Cell Mol Life Sci; 2006 Oct; 63(19-20):2387-96. PubMed ID: 16988787
[TBL] [Abstract][Full Text] [Related]
19. Improved biological and transcriptional activity of monopegylated interferon-alpha-2a isomers.
Foser S; Weyer K; Huber W; Certa U
Pharmacogenomics J; 2003; 3(6):312-9. PubMed ID: 14569259
[TBL] [Abstract][Full Text] [Related]
20. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
